LM-002 (LaNova Medicines)

N/A

Report date: 2025/03/14 15:16:17

Base Information

Drug NameLM-002 (LaNova Medicines)
Drug Alias NameLM-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Cadherin-17
TargetsCadherin-17
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLaNova Medicines Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLaNova Medicines Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A